VUSE ALTO UNAFFECTED BY RECENT FDA DECISION ON VUSE CIRO AND VIBE MENTHOL

The U.S. Food and Drug Administration (FDA) denied premarket tobacco product applications (PMTA) for our Vuse Vibe Tank Menthol 3.0% and Vuse Ciro Cartridge Menthol 1.5%.

• These denials do not impact the legal status of Vuse Alto’s PMTA, which is awaiting further review by FDA.
• These denials also do not impact the prior marketing authorizations for the Vuse Vibe Device, Vuse Vibe Tank Original 3.0%, Vuse Ciro Device, or Vuse Ciro Cartridge Original 1.5%.

We are disappointed in this decision. We are pursuing appropriate legal avenues in order to allow Vuse to continue offering its innovative products to adult nicotine consumers age 21+ without interruption. Although we disagree with the FDA’s decision, we remain committed to working alongside the agency to create A Better Tomorrow™.

Thank you for your patience as we navigate this process. We will continue to provide important updates as additional information becomes available.

The Vuse Team